642 related articles for article (PubMed ID: 18762933)
1. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction.
Verbeeck RK
Eur J Clin Pharmacol; 2008 Dec; 64(12):1147-61. PubMed ID: 18762933
[TBL] [Abstract][Full Text] [Related]
2. Antiarrhythmics: elimination and dosage considerations in hepatic impairment.
Klotz U
Clin Pharmacokinet; 2007; 46(12):985-96. PubMed ID: 18027986
[TBL] [Abstract][Full Text] [Related]
3. Effect of hepatic insufficiency on pharmacokinetics and drug dosing.
Verbeeck RK; Horsmans Y
Pharm World Sci; 1998 Oct; 20(5):183-92. PubMed ID: 9820880
[TBL] [Abstract][Full Text] [Related]
4. Dose adjustment in patients with liver disease.
Delcò F; Tchambaz L; Schlienger R; Drewe J; Krähenbühl S
Drug Saf; 2005; 28(6):529-45. PubMed ID: 15924505
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update.
Morgan DJ; McLean AJ
Clin Pharmacokinet; 1995 Nov; 29(5):370-91. PubMed ID: 8582120
[TBL] [Abstract][Full Text] [Related]
6. Alfentanil-induced miosis as a surrogate measure of alfentanil pharmacokinetics in patients with mild and moderate liver cirrhosis.
Baririan N; Van Obbergh L; Desager JP; Verbeeck RK; Wallemacq P; Starkel P; Horsmans Y
Clin Pharmacokinet; 2007; 46(3):261-70. PubMed ID: 17328584
[TBL] [Abstract][Full Text] [Related]
7. A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.
Johnson TN; Boussery K; Rowland-Yeo K; Tucker GT; Rostami-Hodjegan A
Clin Pharmacokinet; 2010 Mar; 49(3):189-206. PubMed ID: 20170207
[TBL] [Abstract][Full Text] [Related]
8. Effects of liver disease on pharmacokinetics. An update.
Rodighiero V
Clin Pharmacokinet; 1999 Nov; 37(5):399-431. PubMed ID: 10589374
[TBL] [Abstract][Full Text] [Related]
9. Analgesics in patients with hepatic impairment: pharmacology and clinical implications.
Bosilkovska M; Walder B; Besson M; Daali Y; Desmeules J
Drugs; 2012 Aug; 72(12):1645-69. PubMed ID: 22867045
[TBL] [Abstract][Full Text] [Related]
10. Hepatic disease and drug pharmacokinetics.
Williams RL; Mamelok RD
Clin Pharmacokinet; 1980; 5(6):528-47. PubMed ID: 7002418
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and dosage adjustment in patients with renal dysfunction.
Verbeeck RK; Musuamba FT
Eur J Clin Pharmacol; 2009 Aug; 65(8):757-73. PubMed ID: 19543887
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment.
Kearney BP; Yale K; Shah J; Zhong L; Flaherty JF
Clin Pharmacokinet; 2006; 45(11):1115-24. PubMed ID: 17048975
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics in patients with liver disease.
McLean AJ; Morgan DJ
Clin Pharmacokinet; 1991 Jul; 21(1):42-69. PubMed ID: 1914341
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics in liver disease.
Breimer DD
Pharm Weekbl Sci; 1987 Apr; 9(2):79-84. PubMed ID: 3295764
[TBL] [Abstract][Full Text] [Related]
15. Drug metabolism in chronic renal failure.
Pichette V; Leblond FA
Curr Drug Metab; 2003 Apr; 4(2):91-103. PubMed ID: 12678690
[TBL] [Abstract][Full Text] [Related]
16. Liver disease selectively modulates cytochrome P450--mediated metabolism.
Frye RF; Zgheib NK; Matzke GR; Chaves-Gnecco D; Rabinovitz M; Shaikh OS; Branch RA
Clin Pharmacol Ther; 2006 Sep; 80(3):235-45. PubMed ID: 16952490
[TBL] [Abstract][Full Text] [Related]
17. The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil.
Muirhead GJ; Wilner K; Colburn W; Haug-Pihale G; Rouviex B
Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):21S-30S. PubMed ID: 11879256
[TBL] [Abstract][Full Text] [Related]
18. Consequences of renal insufficiency on the hepatic clearance of some drugs.
Balant LP; Dayer P; Fabre J
Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
[TBL] [Abstract][Full Text] [Related]
19. The effect of liver cirrhosis on the regulation and expression of drug metabolizing enzymes.
Elbekai RH; Korashy HM; El-Kadi AO
Curr Drug Metab; 2004 Apr; 5(2):157-67. PubMed ID: 15078193
[TBL] [Abstract][Full Text] [Related]
20. Drug administration in chronic liver disease.
Westphal JF; Brogard JM
Drug Saf; 1997 Jul; 17(1):47-73. PubMed ID: 9258630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
